Trovagene to Present at Leerink Swan Global Healthcare ... (nd European patent applications and issu...)

Trovagene to Present at Leerink Swan Global Healthcare Conference

Date:2/6/2013

nd European patent applications and issued patents that cover testing for HPV and other infectious diseases, cancer, transplantation, prenatal and genetic testing. In addition, it owns worldwide rights to nucleophosmin-1 (NPM1), an informative biomarker for acute myelogenous leukemia (AML) and mutations in the SF3B1 gene, which have been shown to be associated with chemotherapy response in chronic lymphocytic leukemia (CLL) patients, as well as other hematologic malignancies.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimated" and "intend," among others. These forward-looking statements are based on Trovagene's current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, substantial competition; our ability to continue as a going concern; our need for additional financing; uncertainties of patent protection and litigation; uncertainties of government or third party payer reimbursement; limited sales and marketing efforts and dependence upon third parties; and risks related to failure to obtain FDA clearances or approvals and noncompliance with FDA regulations. As with any medical diagnostic tests under development, there are significant risks in the development, regulatory approval and commercialization of new products. There are no guarantees that future clinical trials discussed in this press release will be completed or successful or that any product will receive regulatory approval for any indication or prove to be commercially successful. Trovagene does not undertake an obligation to update or revise any forward-looking statement. Investors should read
'/>"/>

SOURCE Trovagene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Trovagene to be Added to Russell Microcap Index
2. Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
3. Trovagene and Strand Life Sciences Plan Collaboration to Validate and Offer Urine-Based HPV Screening Test in India and South Asia
4. TrovaGene Acquires CLIA - Certified Laboratory
5. TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
6. Probiotic Action Representative Fernando Perez Shares Tips for Parents with Teens Suffering from Acne and Depression
7. Oracle’s Value Chain Summit San Francisco: Track Sponsor NexInfo presents more industry specific solutions
8. Infinata's BioPharm Clinical™ to Present Session on Improving Investigator Selection at CHI’s Summit for Clinical Operations (SCOPE) on February 6 in Miami, FL
9. Fertility Associates of Memphis, World-Renowned Expert in Infertility, Presents Findings to European Conference
10. Salimetrics to Present Workshop on the Integration of Salivary Analytes into Scientific Studies at the Society for Research in Child Development (SRCD) Preconference
11. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals

Post Your Comments:

(Date:6/18/2013)... , June 18, 2013 Techne Corporation (NASDAQ: ... it has agreed to acquire 100% ownership of ... Inc. (Bionostics). Bionostics is a global leader in ... that verify the proper operation of in ... point of care blood glucose and blood gas ...

(Date:6/18/2013)... 2013 As a leading provider ... announces the release of their infographic - " ... , MeMD's goal was to leverage an information ... 2.0, Health 3.0 and mHealth.The infographic features a ... care and the fitness industry in unimaginable ways; ...

(Date:6/18/2013)... (PRWEB) June 18, 2013 ... automated system for rapid bacterial strain typing, announced ... joined the company as Vice President of Engineering. ... for the company’s RESOLUTION™ Microbial Genotyping System ... the benchtop instrument, pathogen-specific assay kits, database and ...

(Date:6/18/2013)... June 18, 2013 Kitware , ... announces a new Fast-Track award from the U.S. Department ... environment (IDAE) for the nuclear power industry. , Construction ... more than 30 years, but the United States’ nuclear ... gains in power plant utilization through improved refueling, maintenance, ...

Breaking Biology Technology:Techne Corporation Announces Acquisition Agreement 2 Techne Corporation Announces Acquisition Agreement 3 Techne Corporation Announces Acquisition Agreement 4 Techne Corporation Announces Acquisition Agreement 5 MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2 PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2 PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3 Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research 2

[0] Techne Corporation Announces Acquisition Agreement [0] MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today [0] PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System [0] Kitware to Develop an Open-Source HPC Design-Analysis Environment for Nuclear Energy Research

... International Associates Inc.,administrator for the HealthShares(TM) Indexes, a ... Funds, today announced the,quarterly rebalancing of the Indexes. ... the Indexes effective before the opening of trading ... Index (HHA) Drop GW Pharmaceuticals, Inc ...

... Mass., March 20 Interleukin,Genetics, Inc. (Amex: ILI ... and webcast on Thursday, March 27, 2008 at 4:30 ... end 2007 financial results and provide an,update on recent ... 877-440-5803 (domestic) or 719-325-4900,(international). The live webcast will be ...

... (Nasdaq:,BIOD) today announced that Gerard Michel, Chief Financial Officer, ... present a,corporate update at the BioCentury Future Leaders Conference ... The conference will be held at,the Millennium Broadway Hotel ... parties may access a link to a live webcast ...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results Biodel Inc. to Present at the BioCentury Future Leaders Conference on March 27th, 2008

(Date:6/18/2013)... , June 19, 2013 Paris Air ... as Geotest-Marvin Test Systems) , a leading provider ... aerospace industries, is demonstrating its solutions this week ... booth 3-C82. With growing challenges including increasingly complex ... demanding efficient, feature-rich, specialized aerospace test solutions that ...

(Date:6/18/2013)... of Medicine have discovered a mechanism that is used ... component of blood typically associated with clotting, were discovered ... seal it off from the rest of the body. ... this week, provide the science community with a ... known that platelets do participate in immunity, but now ...

(Date:6/18/2013)... Department,s National Renewable Energy Laboratory (NREL), and the ... describing a novel cellulose-degrading enzyme from a marine ... as the gribble. , Gribbles are biologically ... to produce their own enzymes instead of using ... eat. New biomass-degrading enzymes from novel sources such ...

Breaking Biology News(10 mins):Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2 Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3 Immunity mechanism discovered 2 Novel enzyme from tiny gribble could prove a boon for biofuels research 2

[0] Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show [0] Immunity mechanism discovered [0] Novel enzyme from tiny gribble could prove a boon for biofuels research

... Many would assume that "mounting an immune response" or ... thing. Now, research at the University of California, ... inflammation associated with the progression of tumors actually plays ... , The research, appearing online March 19 in advance ...

... eco-friendly, clean-burning fuel. But if every vehicle in the ... instead of pure gasoline, the number of respiratory-related deaths ... study by Stanford University atmospheric scientist Mark Z. Jacobson. ... edition of the journal Environmental Science & Technology (ES&T). ...

... the world's most endangered cat, the Amur or Far Eastern ... to 34 are left in the wild, renewing fears for ... World Wildlife Fund along with the Wildlife Conservation Society and ... Science, conducted a routine snow-track census of leopard numbers. ...

Cached Biology News:Inflammation may play role in metastasis of prostate cancer 2 Inflammation may play role in metastasis of prostate cancer 3 Ethanol vehicles pose a significant risk to human health, study finds 2 Ethanol vehicles pose a significant risk to human health, study finds 3 Amur leopard still on the brink of extinction, scientists say 2

Inflammation may play role in metastasis of prostate cancer Ethanol vehicles pose a significant risk to human health, study finds Amur leopard still on the brink of extinction, scientists say

Contains L-glutamine...

... does not share significant homology with ... is expressed in the central nervous ... stomach. One important role PEBP ... activity against several serine proteases including ...

...

Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25....

Biology Products:

GIBCO BGJb Medium (Fitton-Jackson Modification) (1X) liquid from Invitrogen Anti-PEBP Polyclonal Antibody, unconjugated, Clone ZLK.17 from Invitrogen TriContinentMultiWash III from Femto Scientific MitoCapture Apoptosis Detection Kit from BioVision